FIL Ltd reduced its stake in Genpact Limited (NYSE:G - Free Report) by 23.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,727,553 shares of the business services provider's stock after selling 1,153,146 shares during the period. FIL Ltd owned 2.11% of Genpact worth $160,098,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in G. SRH Advisors LLC bought a new stake in Genpact in the 4th quarter worth about $26,000. Atlas Capital Advisors Inc. lifted its position in shares of Genpact by 55.8% in the fourth quarter. Atlas Capital Advisors Inc. now owns 603 shares of the business services provider's stock worth $26,000 after buying an additional 216 shares in the last quarter. Manchester Capital Management LLC bought a new position in shares of Genpact during the 4th quarter valued at approximately $38,000. Smartleaf Asset Management LLC grew its stake in shares of Genpact by 416.5% in the 4th quarter. Smartleaf Asset Management LLC now owns 971 shares of the business services provider's stock worth $41,000 after buying an additional 783 shares in the last quarter. Finally, UMB Bank n.a. increased its stake in Genpact by 55.7% during the fourth quarter. UMB Bank n.a. now owns 1,210 shares of the business services provider's stock worth $52,000 after acquiring an additional 433 shares during the last quarter. 96.03% of the stock is owned by hedge funds and other institutional investors.
Genpact Stock Performance
Shares of Genpact stock traded up $0.38 on Monday, reaching $47.68. 162,737 shares of the stock were exchanged, compared to its average volume of 1,349,065. Genpact Limited has a twelve month low of $30.23 and a twelve month high of $56.76. The company has a quick ratio of 1.85, a current ratio of 2.16 and a debt-to-equity ratio of 0.50. The firm has a market capitalization of $8.38 billion, a price-to-earnings ratio of 16.79, a PEG ratio of 1.84 and a beta of 1.06. The business has a 50 day moving average price of $51.00 and a two-hundred day moving average price of $45.83.
Genpact (NYSE:G - Get Free Report) last announced its quarterly earnings results on Thursday, February 6th. The business services provider reported $0.82 earnings per share for the quarter, missing the consensus estimate of $0.86 by ($0.04). Genpact had a net margin of 10.77% and a return on equity of 22.50%. Analysts anticipate that Genpact Limited will post 3.21 earnings per share for the current fiscal year.
Genpact Increases Dividend
The business also recently declared a quarterly dividend, which was paid on Wednesday, March 26th. Investors of record on Tuesday, March 11th were paid a $0.17 dividend. The ex-dividend date was Tuesday, March 11th. This is a positive change from Genpact's previous quarterly dividend of $0.15. This represents a $0.68 dividend on an annualized basis and a yield of 1.43%. Genpact's dividend payout ratio (DPR) is currently 23.94%.
Insider Buying and Selling at Genpact
In related news, CEO Balkrishan Kalra sold 13,600 shares of the stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $48.89, for a total value of $664,904.00. Following the completion of the transaction, the chief executive officer now directly owns 310,246 shares in the company, valued at approximately $15,167,926.94. This represents a 4.20 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. 2.80% of the stock is currently owned by insiders.
Wall Street Analysts Forecast Growth
G has been the subject of several analyst reports. Needham & Company LLC raised their target price on shares of Genpact from $55.00 to $65.00 and gave the stock a "buy" rating in a report on Friday, February 7th. TD Cowen upgraded Genpact from a "hold" rating to a "buy" rating and raised their price target for the company from $45.00 to $60.00 in a research note on Friday, February 7th. Jefferies Financial Group upgraded Genpact from a "hold" rating to a "buy" rating and upped their target price for the stock from $44.00 to $55.00 in a report on Tuesday, January 21st. Finally, Mizuho raised their price target on shares of Genpact from $45.00 to $55.00 and gave the company a "neutral" rating in a report on Monday, February 10th. Six equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat.com, Genpact currently has a consensus rating of "Hold" and a consensus target price of $48.44.
View Our Latest Report on G
About Genpact
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
See Also

Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.